Fusogenic Viruses in Oncolytic Immunotherapy - Wikidata - wikimedia - TriplyDB

Fusogenic Viruses in Oncolytic Immunotherapy

Fusogenic Viruses in Oncolytic Immunotherapy

http://www.wikidata.org/entity/Q56971929

about

Fusogenic Viruses in Oncolytic Immunotherapy

http://www.wikidata.org/entity/Q56971929

description

scientific article published on 26 June 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2018

@uk

name

Fusogenic Viruses in Oncolytic Immunotherapy

@en

Fusogenic Viruses in Oncolytic Immunotherapy

@nl

type

label

Fusogenic Viruses in Oncolytic Immunotherapy

@en

Fusogenic Viruses in Oncolytic Immunotherapy

@nl

prefLabel

Fusogenic Viruses in Oncolytic Immunotherapy

@en

Fusogenic Viruses in Oncolytic Immunotherapy

@nl

P1433

Q56971929-CC65F36B-4372-4CD9-BF3A-DF4040CA406B

P1476

Q56971929-A7B7F3A6-AFFB-4988-B67B-54332D09A4DF

P2093

Q56971929-99062F65-3B8F-4514-B9BB-21E5B5E332E8

P2860

Q56971929-01FD2506-329D-475A-8A72-87D2695F79A2

Q56971929-035BDD12-AD80-4533-A4C9-C1B7738D5C40

Q56971929-05762B91-C04B-49BB-B417-F025A25F0B9E

Q56971929-0CC583B4-C9E8-4488-AB06-27F68254116A

Q56971929-0F4D2D75-757C-445C-A2AA-1C3C0E076B74

Q56971929-12D60C84-860D-4345-8A02-59950D240B2E

Q56971929-134F882C-8016-4F9B-964C-0D74075FECE9

Q56971929-13746F66-A5A7-49EB-BC16-BD71D2649206

Q56971929-1A2F27B0-5B80-4F28-8DD6-48F5291B3CAF

Q56971929-1DD12155-AFC0-487A-9F90-2A5BFCD7F0D8

P304

Q56971929-D648A5A1-DC1B-416C-AF38-959C1579BC6A

P31

Q56971929-29FFDB55-796A-4CA3-B9CF-8917ADF4546E

P356

Q56971929-A7D9842C-5B92-4BCE-8E29-0EC689A0C38C

P407

Q56971929-F87E9818-0B7D-4DE4-83DC-6E7204FB2C68

P433

Q56971929-5E3721B2-09E0-4015-B542-5AC1CFB9A820

P478

Q56971929-B44741A2-0A4C-40C8-85BA-558C229464F9

P50

Q56971929-9315567C-68EB-4B22-8151-4EE08EFA0C2B

Q56971929-977535A7-659C-42C4-B5F5-A1FF76601C3D

P577

Q56971929-E246F1E2-BB99-430D-8BD2-1E2BAF4983D4

P698

Q56971929-9EC8E6C5-A390-4FBA-A992-876C2660BBFA

P921

Q56971929-178C4BA0-D97E-454A-86F7-F588CAA46D9F

Q56971929-7F0ADD36-23D6-4385-956B-F66EDFA7184B

Q56971929-D8782B54-8A98-4075-A74E-5A0341C1375A

P932

Q56971929-812AD254-950B-4723-AAC7-13F13AB293E6

P356

CANCERS10070216

P1433

P1476

Fusogenic Viruses in Oncolytic Immunotherapy

@en

P2093

Teresa Krabbe

http://www.w3.org/2001/XMLSchema#string

P2860

Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion

Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma

Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses

A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire

Entry and uncoating of enveloped viruses

Cell-cell fusion induced by measles virus amplifies the type I interferon response.

Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme

The Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) Protein

Viral membrane fusion.

Mechanisms of apoptosis induction by the HIV-1 envelope

P304

216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/CANCERS10070216

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer Altomonte

P577

2018-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29949934

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

cancer research

P932

6070779

http://www.w3.org/2001/XMLSchema#string